News
AAA Announces Research Collaboration Partnership with the Institut Curie in Paris
July 1, 2010 - AAA has signed an agreement with the Institut Curie to build, install and operate a pharmaceutical laboratory for radiopharmaceuticals production at the Institut Curie's René Huguenin specialist cancer hospital in Saint-Cloud, Paris.
The cyclotron will guarantee the supply of high quality radiopharmaceuticals for the hospital's two PET (Positron...
AAA acquires BioSynthema, Inc. (St. Louis, Missouri) to enter radiopharmaceutical cancer therapeutic market
Advanced Accelerator Applications announced that it has signed the definitive Stock Purchase Agreement for the acquisition of BioSynthema, Inc . The purchase is subject to the final completion of the transaction, which is expected in mid-June. As part of the transaction, BioSynthema ’s founding...
Press Releases
23 August 2010
Un cyclotron pour mieux diagnostiquer les tumeurs et améliorer la recherche en médecine nucléaire
09 August 2010
Advanced Accelerator Applications Announces Research and Supply Partnership with the Institut Curie in Paris
Events
October 9 - 13, 2010 - Vienna, Austria
Annual Congress of the European Association of Nuclear Medicine (EANM)
May 8 - 11, 2010 - Nice, France
48ème Colloque de Médecine Nucléaire de Langue Française - Société Française de Médecine Nucléaire et Imagerie Moléculaire (SFMN)